Development of new tools to explore organelle calcium dynamics in vivo: a new fret-based calcium sensor and a mitochondria targeted channelrhodopsin
Year: 2015
Type: article
Abstract: The first part of this thesis aims to develop new tools to explore mitochondrial Ca2+ dynamic in vivo by the improvement of a mitochondria targeting Cameleon probes and by creating a mitochondria targeted Channelrhodopsin. Genetically encoded calcium indicators (GECIs) allow quantitative Ca2+ measurements in different experimental models. Organelle-specific targeting signals are fused with the GECI’s sequence, achieving selective targeting to a specific organelle or cytoplasmic domain. Moreover, GECI’s coding sequences can be placed under the control of tissue specific or inducible promoters, allowing spatial and temporal control of their expression. Different types of GECIs have been created: in our laboratory we use a class of FRET-based Ca2+ sensors, called Cameleons. FRET (Förster resonance energy transfer) microscopy detects the direct transfer of energy from a donor to an acceptor fluorescence protein (FP) in a living cell. Cameleon structure consists of two Ca2+-responsive elements that alter the efficiency of FRET between two FPs: a cyan fluorescent protein (CFP), the donor, and a yellow fluorescent protein (cpV), the acceptor. The two Ca2+-responsive elements are Calmodulin (CaM) and the CaM-binding domain of myosin light chain kinase. As reported in the beginning, the aim of this study is to develop novel molecular sensors and new methodologies to express the probes in vivo in intact tissues as well as in organisms in order to explore organelle Ca2+ dynamics in vivo (in particularly in brain and heart). One of the limitations of Cameleon probes, especially critical for in vivo applications, is the low fluorescence of CFP, reducing the maximal obtainable signal-to-noise ratio, and a multi-exponential lifetime, indicating the presence of multiple excited-state decay pathways. Recently, a brighter and more stable FP, compared to CFP, has been developed: mCerulean3. It has high fluorescence quantum yield and high photostability, making this protein a good donor candidate in Cameleon probes. For this reason, CFP has been replaced with mCerulean3 in two different Cameleons: the cytosolic D3cpv and the mitochondria-targeted probe named 4mtD3cpv. The new probes have been tested in different cell types: HeLa, neonatal rat cardiomyocytes and neonatal mouse neurons. The brightness, the photostability, the pH-sensitivity and the dissociation constant (Kd) of the new probes have also been measured in situ and the data show a clear improvement in brightness and in photostability, compared to the original Cameleons, in both cytosolic and mitochondrial probes. The only drawback of the new probes is a reduced amplitude (about 20-30%) in the maximum change in the fluorescence emission ratio due to Ca2+ binding (dynamic range). In order to extend the dynamic range different approaches have been used. The addition of 16 glycines between the two Ca2+ responsive elements allowed us to generate a new cytosolic probe (D3mCerulean3+16) with an increased dynamic range (+ 20%). Similarly, we have modified the mitochondrial probe, starting from the targeting sequence, each N-terminal sequence of COX-VIII (subunit VIII of human cytochrome C oxidase) was elongated of 5 aminoacids. Indeed, 24 h after transfection a significant mis-localization in the cytosol was observed with the original probe, while the mis-targeting of the modified targeting sequence containing probe was decreased. Moreover, the reduction in the dynamic range due to the mCerulean3 presence was almost fully recovered adding the 16 glycines linker. We than analysed the effect of pH, observing a general stability of all the probe variants in the pH range tested. Finally, we evaluated the Ca2+ affinity of all the mitochondrial variants generated so far, obtaining a Kd of 0.06 μM and one of 10.84 μM in 4mtD3cpV, a Kd of 6,5 μM in 4mtD3mCerulean3 and a Kd of 0.03 μM and one of 10.7 μM in 4mtD3mCerulean3+16. To better characterize the new cytosolic and mitochondrial Cameleon probes, we purified the proteins expressed in E.Coli in order to measure also in vitro all the parameters described above. Up to now only preliminary data have been obtained, however a comparison of in situ and in vitro data suggests that the DR calculated for cytosolic probes is about 3, while that for a mitochondria like environment is about 2.5. Concerning the Ca2+ affinity, just few [Ca2+] concentrations have been tested so far, therefore all the mitochondrial and cytosolic probes display a single Kd. However, further experiments are required to confirm the in vitro calculated Kd. In parallel, we are also assessing another method to measure Ca2+ with FRET-GECIs, as an alternative of the classical intensity-based method. We are indeed employing FLIM technique that measures the lifetime of FPs (the time the molecule spend in the exited state), which is totally independent from phenomena such as probe photobleaching, expression level, image shading. Preliminary results in cells expressing all the Camelon probes described so far, suggest the presence of homo-FRET phenomena and mCerulean3-based Ca2+ sensors seem to be less affected by them. Finally, to express the new probes in vivo we are testing three strategies: i) adeno-associated virus (serotype 9) with cardiac tropism viral vectors; ii) adeno-associated virus (serotype 9) with neuron-specific promoters (synapsin promoter) for intracranial injection; iii) transgenic mice. These strategies will allow us to perform in vivo Ca2+ measurements in different tissues and subcellular compartments. We have just generated the AAV9 for the expression of the D3mCerulean3 and 4mD3mCerulean3 under the control of CMV promoter. A good expression levels in heart was obtained through intraperiotneal injection of neonatal mice. In conclusion, the results obtained so far make the mCerulean3-based Cameleons an attractive choice for in vivo experiments. To study the role of mitochondria in situ and in vivo, we also took advantage of an optogenetic tool: Channel Rhodopsins (ChRs). ChRs represent the only type of ion channels directly gated by light. When excited by light, ChRs open and depolarize the plasma membrane. For activation, opsins require binding of retinal, a vitamin A–related organic cofactor. In collaboration with Prof. Sekler’s group (Ben-Gurion University-Israel), we have developed a new mitochondria-targeted ChR, called mitochondrial Stabilized Step Function Opsin (4mt-SSFO). This ChR variant was modified to stabilize the conducting state of the channel: SSFO deactivation occurs in 30 minutes after a brief pulse of activating blue light (460-480 nm). It has also been reported the possibility to terminate the photocurrents with red light. To create a non-functional control, a truncated form Chr2(TR) lacking retinal binding site was generated. The targeting of proteins to the inner mitochondrial membrane (IMM) was obtained fusing four signal sequences, derived from human cytochrome C oxidase subunit VIII sequence, to the N-terminus of ChR. To verify the correct topology of the probe, confocal microscopy, elecrtophisiological recordings and fluorescence quenching experiments were carried out. When 4mtSSFO-YFP is properly inserted in the IMM, its C-terminal YFP tag should face the mitochondrial matrix. Indeed, the application of proteinase K to Digitonin permeabilized cells did not cause a significant reduction of 4mtChR2B-YFP signal, while that of N33D3cpv (a probe in which the YFP is located on the cytoplasmic surface of the OMM) is completely abolished. Trypan blue addition, that is permeable across the OMM, but not the IMM, did not affect the fluorescence of 4mtSSFO-YFP or that of the matrix located Cameleon 4mtD3cpv. The 4mtD3cpv fluorescence however was totally lost after alamethicin application that permeabilizes both mitochondrial membranes and releases all matrix proteins into the medium, while the fluorescence of 4mtSSFO-YFP was not affected by the latter treatment, as expected for a membrane bound protein. Taken together these data are consistent with a proper IMM localization. The new mitochondrial 4mtSSFO-YFP constructs were then tested in situ for their ability to change the mitochondrial membrane potential in response to light, resulting in a significant organelle depolarization in cells expressing 4mtSSFO-YFP, while no effect was induced by blue light in control cells. We then analysed in more details the effects of mitochondrial depolarization on mitochondrial Ca2+ uptake using two genetically encoded probes, 4mtD3cpv and mt-aequorin. Both approaches demonstrate that the depolarization of mitochondria triggered by photo-activation of the channel causes, as predicted, a significant reduction in the amplitude of the mitochondrial Ca2+ rise observed upon stimulation of HeLa cells with an IP3-generating agonist. Thus, we generated a tool able to modulate diverse mitochondria activities in a temporary-controlled, reversible (at least in principle) and cell-specific manner, offering an approach to quantitatively investigate mitochondrial role in a large variety of critical cellular processes. In the second part of the thesis, the investigation was focused on the role of Presenilins in Ca2+dyshomeostasis associated to Alzheimer's Disease (AD) using a single cell analysis approach and focusing on the role of AD Presenilin 1 and Presenilin 2 mutations in the modulation of Capacitative Calcium Entry (CCE). AD is the most frequent form of dementia. A small percentage of cases is inherited (Familial AD, FAD) and is due to dominant mutations on three genes, coding for Amyloid Precursor Protein (APP), Presenilin-1 (PS1) and Presenilin-2 (PS2). Mutations in these genes cause alterations in the cleavage of APP by a PS1- or PS2- containing enzyme, named y-secretase complex, thus leading to an increase in the ratio between Abeta42 and Abeta40, the two main peptides eventually derived from APP maturation. This event, in turn, leads to an increa
Author: Elisa Greotti
Language: English
Subfield: Biophysics
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2193825612
